Earnings6 reported quarters · next on Feb 22, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Nov 5, 2026
$0.24
$0.21
$471.8M
$471.4M
EPS beatRevenue in line
Q2 FY2026reported Aug 4, 2026
$0.21
$0.14
$458.8M
$410.4M
EPS beatRevenue beat
Q1 FY2026reported May 6, 2026
$0.16
$0.13
$371.0M
$345.0M
EPS beatRevenue beat
Q4 FY2025reported Feb 23, 2026
$0.18
$0.16
$345.1M
$327.2M
EPS beatRevenue beat
Q3 FY2025reported Nov 4, 2025
$0.14
$0.13
$347.6M
$322.0M
EPS beatRevenue beat
Q2 FY2025reported Aug 7, 2025
$0.11
$0.10
$351.5M
$306.5M
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.
Each firm's latest price target on KTOS, newest first
Firm
Rating
Target
Action
Date
Jefferies
Buy
$50
Cut from $68
Piper Sandler
Overweight
$61
Cut from $75
Oppenheimer
Outperform
$50
Initiated
Macquarie
Outperform
$70
Initiated
Goldman Sachs
Buy
$77
Target set
Barclays
Overweight
$90
Initiated
Rothschild & Co Redburn
Buy
$70
Initiated
Guggenheim
Buy
$74
Initiated
Truist Securities
Buy
$104
Cut from $135
BTIG
Buy
$104
Raised from $100
Stifel
Buy
$115
Cut from $134
Canaccord
Buy
$135
Raised from $130
Cantor Fitzgerald
Overweight
$100
Target set
Wedbush
Outperform
$85
Initiated
RBC Capital
Outperform
$80
Target set
UBS
Neutralrated Nov 9, 2026
$82
Target set
KeyBanc
Overweight
$130
Raised from $90
Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
4 other firms rated KTOS in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 12, 2026.
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
The largest estimated position is in the $100,001 - $250,000 band. Estimate, as of Nov 12, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
What the filings on KTOS show and how current they are.
Are insiders buying or selling KTOS?
Across the 12 most recent open-market filings shown here, 0 were purchases and 12 were sales. 11 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress hold KTOS?
1 member of Congress reports a position in KTOS in the estimate we hold as of Nov 12, 2026. The estimated position belongs to Bill Hagerty. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are KTOS trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows.